
What is the prognosis for new centrally-acting anti-obesity drugs?
Keywords: Obesity; CNS drugs; Drug targets; Animal models; Clinical trialsAgRP, agouti-related peptide; BD or bid, twice daily; BMI, body mass index; CB, cannabinoid; mCPP, m-chlorophenylpiperazine; DBP, diastolic blood pressure; DIO, dietary-induced obesity; DPP-4